drugset / Trial / NCT01626872
Long-Term Study of MP-214 in Patients With Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to evaluate the long-term safety, tolerability, and efficacy of MP-214 in patients with schizophrenia.
Timeline
- Start
- 2012-09
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cariprazine | Small molecule | 3 mg | — |
| Subject | Cariprazine | Small molecule | 6 mg | — |
| Subject | Cariprazine | Small molecule | 9 mg | — |
| Comparator | Risperidone | Other / unclassified | 4 mg | — |